Estrogen receptor DNA binding is not required for estrogen-induced breast cell growth

Molecular and Cellular Endocrinology

Volumn 277, Issue 1-2, 2007, Pages 13-25

  DeNardo, David G ^a   Cuba, Valerie L ^a   Kim, HeeTae ^a   Wu, Kendall ^a   Lee, Adrian V ^a   Brown, Powel H ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Breast cancer; Cell growth; Estrogen; Mitogenesis; Transcription factor crosstalk

Indexed keywords

CYCLIN D1; DNA; ESTROGEN; ESTROGEN RECEPTOR ALPHA; MUTANT PROTEIN; MYC PROTEIN; PHOSPHOTRANSFERASE; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR SP1;

ARTICLE; BREAST CANCER; BREAST CELL; CELL CYCLE REGULATION; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN CELL; MOLECULAR CLONING; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION;

BREAST; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL MEMBRANE; CELL PROLIFERATION; CLONE CELLS; DNA, NEOPLASM; ENZYME ACTIVATION; ESTROGEN RECEPTOR ALPHA; ESTROGENS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MODELS, BIOLOGICAL; MUTATION; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-AKT; RESPONSE ELEMENTS; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; ZINC FINGERS;

EID: 34748842643     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2007.07.006     Document Type: Article

References (50)

1. Andrews N.C., and Faller D.V. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 19 (1991) 2499
2. Arnold S.F., Obourn J.D., Jaffe H., and Notides A.C. Serine 167 is the major estradiol-induced phosphorylation site on the human estrogen receptor. Mol. Endocrinol. 8 (1994) 1208-1214
3. Aronica S.M., Kraus W.L., and Katzenellenbogen B.S. Estrogen action via the cAMP signaling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 8517-8521
4. Barron-Gonzalez A., and Castro Romero I. Re-expression of estrogen receptor alpha using a tetracycline-regulated gene expression system induced estrogen-mediated growth inhibition of the MDA-MB-231 breast cancer cell line. Biochem. Cell Biol. 82 (2004) 335-342
5. Brown P.H., Kim S.H., Wise S.C., Sabichi A.L., and Birrer M.J. Dominant-negative mutants of cJun inhibit AP-1 activity through multiple mechanisms and with different potencies. Cell Growth Differ. 7 (1996) 1013-1021
6. Carroll J.S., and Brown M. Estrogen receptor target gene: an evolving concept. Mol. Endocrinol. 20 (2006) 1707-1714
7. Carroll J.S., Liu X.S., Brodsky A.S., Li W., Meyer C.A., Szary A.J., Eeckhoute J., Shao W., Hestermann E.V., Geistlinger T.R., Fox E.A., Silver P.A., and Brown M. Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 122 (2005) 33-43
8. Carroll J.S., Meyer C.A., Song J., Li W., Geistlinger T.R., Eeckhoute J., Brodsky A.S., Keeton E.K., Fertuck K.C., Hall G.F., Wang Q., Bekiranov S., Sementchenko V., Fox E.A., Silver P.A., Gingeras T.R., Liu X.S., and Brown M. Genome-wide analysis of estrogen receptor binding sites. Nat. Genet. 38 (2006) 1289-1297
9. Cicatiello L., Addeo R., Sasso A., Altucci L., Petrizzi V.B., Borgo R., Cancemi M., Caporali S., Caristi S., Scafoglio C., Teti D., Bresciani F., Perillo B., and Weisz A. Estrogens and progesterone promote persistent CCND1 gene activation during G1 by inducing transcriptional derepression via c-Jun/c-Fos/estrogen receptor (progesterone receptor) complex assembly to a distal regulatory element and recruitment of cyclin D1 to its own gene promoter. Mol. Cell Biol. 24 (2004) 7260-7274
10. Denardo D.G., Kim H.T., Hilsenbeck S., Cuba V., Tsimelzon A., and Brown P.H. Global gene expression analysis of ER transcription factor cross-talk in breast cancer: Identification of estrogen-induced/AP-1-dependent genes. Mol. Endocrinol. 28 (2004) 28
11. Doisneau-Sixou S.F., Sergio C.M., Carroll J.S., Hui R., Musgrove E.A., and Sutherland R.L. Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells. Endocr. Relat. Cancer 10 (2003) 179-186
12. Dubik D., and Shiu R.P. Transcriptional regulation of c-myc oncogene expression by estrogen in hormone-responsive human breast cancer cells. J. Biol. Chem. 263 (1988) 12705-12708
13. Dubik D., and Shiu R.P. Mechanism of estrogen activation of c-myc oncogene expression. Oncogene 7 (1992) 1587-1594
14. Harris J., Morrow M., and Bodadonna G. Cancer of the Breast (1993), J.B. Lippincott Co, Philadelphia
15. Jakacka M., Ito M., Martinson F., Ishikawa T., Lee E.J., and Jameson J.L. An estrogen receptor (ER)alpha deoxyribonucleic acid-binding domain knock-in mutation provides evidence for nonclassical ER pathway signaling in vivo. Mol. Endocrinol. 16 (2002) 2188-2201
16. Jakacka M., Ito M., Weiss J., Chien P.Y., Gehm B.D., and Jameson J.L. Estrogen receptor binding to DNA is not required for its activity through the nonclassical AP1 pathway. J. Biol. Chem. 276 (2001) 13615-13621
17. Jiang S.Y., and Jordan V.C. Growth regulation of estrogen receptor-negative breast cancer cells transfected with complementary DNAs for estrogen receptor. J. Natl. Cancer Inst. 84 (1992) 580-591
18. Johnson W.E., Li W., Meyer C.A., Gottardo R., Carroll J.S., Brown M., and Liu X.S. Model-based analysis of tiling-arrays for ChIP-chip. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 12457-12462
19. Kelly M.J., Lagrange A.H., Wagner E.J., and Ronnekleiv O.K. Rapid effects of estrogen to modulate G protein-coupled receptors via activation of protein kinase A and protein kinase C pathways. Steroids 64 (1999) 64-75
20. Klinge C.M. Estrogen receptor interaction with estrogen response elements. Nucleic Acids Res. 29 (2001) 2905-2919
21. Kushner P.J., Agard D., Feng W.J., Lopez G., Schiau A., Uht R., Webb P., and Greene G. Oestrogen receptor function at classical and alternative response elements. Novartis Found Symp. 230 (2000) 20-26 discussion 27-40
22. Kushner P.J., Agard D.A., Greene G.L., Scanlan T.S., Shiau A.K., Uht R.M., and Webb P. Estrogen receptor pathways to AP-1. J. Steroid Biochem. Mol. Biol. 74 (2000) 311-317
23. Lazennec G., and Katzenellenbogen B.S. Expression of human estrogen receptor using an efficient adenoviral gene delivery system is able to restore hormone-dependent features to estrogen receptor-negative breast carcinoma cells. Mol. Cell Endocrinol. 149 (1999) 93-105
24. Le Goff P., Montano M.M., Schodin D.J., and Katzenellenbogen B.S. Phosphorylation of the human estrogen receptor. Identification of hormone-regulated sites and examination of their influence on transcriptional activity. J. Biol. Chem. 269 (1994) 4458-4466
25. Le Mellay V., Grosse B., and Lieberherr M. Phospholipase C beta and membrane action of calcitriol and estradiol. J. Biol. Chem. 272 (1997) 11902-11907
26. Levenson A.S., and Jordan V.C. Transfection of human estrogen receptor (ER) cDNA into ER-negative mammalian cell lines. J. Steroid Biochem. Mol. Biol. 51 (1994) 229-239
27. Levin E.R. Cellular Functions of the Plasma Membrane Estrogen Receptor. Trends Endocrinol. Metab. 10 (1999) 374-377
28. Liu M.M., Albanese C., Anderson C.M., Hilty K., Webb P., Uht R.M., Price Jr. R.H., Pestell R.G., and Kushner P.J. Opposing action of estrogen receptors alpha and beta on cyclin D1 gene expression. J. Biol. Chem. 277 (2002) 24353-24360
29. Liu Y., Ludes-Meyers J., Zhang Y., Munoz-Medellin D., Kim H.T., Lu C., Ge G., Schiff R., Hilsenbeck S.G., Osborne C.K., and Brown P.H. Inhibition of AP-1 transcription factor causes blockade of multiple signal transduction pathways and inhibits breast cancer growth. Oncogene 21 (2002) 7680-7689
30. Ludes-Meyers J.H., Liu Y., Munoz-Medellin D., Hilsenbeck S.G., and Brown P.H. AP-1 blockade inhibits the growth of normal and malignant breast cells. Oncogene 20 (2001) 2771-2780
31. Migliaccio A., Di Domenico M., Castoria G., De Falco A., Bontempo P., Nola E., and Auricchio F. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J. 15 (1996) 1292-1300
32. Musgrove E.A., Wakeling A.E., and Sutherland R.L. Points of action of estrogen antagonists and a calmodulin antagonist within the MCF-7 human breast cancer cell cycle. Cancer Res. 49 (1989) 2398-2404
33. Oesterreich S., Zhang P., Guler R.L., Sun X., Curran E.M., Welshons W.V., Osborne C.K., and Lee A.V. Re-expression of estrogen receptor alpha in estrogen receptor alpha-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth. Cancer Res. 61 (2001) 5771-5777
34. Osborne C.K. Tamoxifen in the treatment of breast cancer. N. Engl. J. Med. 339 (1998) 1609-1618
35. Prall O.W., Rogan E.M., Musgrove E.A., Watts C.K., and Sutherland R.L. c-Myc or cyclin D1 mimics estrogen effects on cyclin E-Cdk2 activation and cell cycle reentry. Mol. Cell Biol. 18 (1998) 4499-4508
36. Ray P., Ghosh S.K., Zhang D.H., Ray A., Stein B., and Yang M.X. Repression of interleukin-6 gene expression by 17 beta-estradiol: inhibition of the DNA-binding activity of the transcription factors NF-IL6 and NF-kappa B by the estrogen receptor Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta. FEBS Lett. 409 (1997) 79-85
37. Razandi M., Pedram A., and Levin E.R. Estrogen signals to the preservation of endothelial cell form and function. J. Biol. Chem. 275 (2000) 38540-38546
38. Razandi M., Pedram A., and Levin E.R. Plasma membrane estrogen receptors signal to antiapoptosis in breast cancer. Mol. Endocrinol. 14 (2000) 1434-1447
39. Razandi M., Pedram A., Park S.T., and Levin E.R. Proximal events in signaling by plasma membrane estrogen receptors. J. Biol. Chem. 278 (2003) 2701-2712 Epub 2002 Nov 05
40. Sabbah M., Courilleau D., Mester J., Redeuilh G., Castro-Rivera E., Samudio I., and Safe S. Estrogen induction of the cyclin D1 promoter: involvement of a cAMP response-like element Estrogen regulation of cyclin D1 gene expression in ZR-75 breast cancer cells involves multiple enhancer elements. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 11217-11222
41. Safe S. Transcriptional activation of genes by 17 beta-estradiol through estrogen receptor-Sp1 interactions. Vitam. Horm. 62 (2001) 231-252
42. Shou J., Massarweh S., Osborne C.K., Wakeling A.E., Ali S., Weiss H., Schiff R., Schiff R., Massarweh S.A., Shou J., Bharwani L., Mohsin S.K., and Osborne C.K. Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer Cross-talk between estrogen receptor and growth factor pathways as a molecular target for overcoming endocrine resistance. J. Natl. Cancer Inst. 96 (2004) 926-935
43. Singleton D.W., Feng Y., Chen Y., Busch S.J., Lee A.V., Puga A., and Khan S.A. Bisphenol-A and estradiol exert novel gene regulation in human MCF-7 derived breast cancer cells. Mol. Cell Endocrinol. 221 (2004) 47-55
44. Stein B., and Yang M.X. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta. Mol. Cell Biol. 15 (1995) 4971-4979
45. Sutherland R.L., Hall R.E., Taylor I.W., Green M.D., and Reddel R.R. Cell proliferation kinetics of MCF-7 human mammary carcinoma cells in culture and effects of tamoxifen on exponentially growing and plateau-phase cells Tamoxifen induces accumulation of MCF 7 human mammary carcinoma cells in the G0/G1 phase of the cell cycle. Cancer Res. 43 (1983) 3998-4006
46. Taylor I.W., Hodson P.J., Green M.D., and Sutherland R.L. Effects of tamoxifen on cell cycle progression of synchronous MCF-7 human mammary carcinoma cells. Cancer Res. 43 (1983) 4007-4010
47. Tesarik J., and Mendoza C. Nongenomic effects of 17 beta-estradiol on maturing human oocytes: relationship to oocyte developmental potential. J. Clin. Endocrinol. Metab. 80 (1995) 1438-1443
48. Tsai M.J., and O'Malley B.W. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Ann. Rev. Biochem. 63 (1994) 451-486
49. Weigel N.L., and Zhang Y. Ligand-independent activation of steroid hormone receptors. J. Mol. Med. 76 (1998) 469-479
50. Weinberg R.A. The retinoblastoma protein and cell cycle control. Cell 81 (1995) 323-330